ZBTB34
Zinc finger and BTB domain-containing protein 34
Also known as: ZBT34_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8NCN2
- Gene
- ZBTB34
- Canonical length
- 500 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for ZBTB34 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
500 residues, UniProt reviewed canonical sequence.
>Q8NCN2|ZBTB34
1 MDSSSFIQFD VPEYSSTVLS QLNELRLQGK LCDIIVHIQG QPFRAHKAVL AASSPYFRDH
61 SALSTMSGLS ISVIKNPNVF EQLLSFCYTG RMSLQLKDVV SFLTAASFLQ MQCVIDKCTQ
121 ILESIHSKIS VGDVDSVTVG AEENPESRNG VKDSSFFANP VEISPPYCSQ GRQPTASSDL
181 RMETTPSKAL RSRLQEEGHS DRGSSGSVSE YEIQIEGDHE QGDLLVRESQ ITEVKVKMEK
241 SDRPSCSDSS SLGDDGYHTE MVDGEQVVAV NVGSYGSVLQ HAYSYSQAAS QPTNVSEAFG
301 SLSNSSPSRS MLSCFRGGRA RQKRALSVHL HSDLQGLVQG SDSEAMMNNP GYESSPRERS
361 ARGHWYPYNE RLICIYCGKS FNQKGSLDRH MRLHMGITPF VCKFCGKKYT RKDQLEYHIR
421 GHTDDKPFRC EICGKCFPFQ GTLNQHLRKN HPGVAEVRSR IESPERTDVY VEQKLENDAS
481 ASEMGLDSRM EIHTVSDAPDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZBTB34 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 14 nTPM
- retina: 12 nTPM
- placenta: 6.3 nTPM
- spleen: 5 nTPM
- lymph node: 4.5 nTPM
- thymus: 4.5 nTPM
Single-cell type
- neutrophils: 64 nCPM
- platelets: 52 nCPM
- late spermatids: 41 nCPM
- neutrophil progenitors: 36 nCPM
- cone photoreceptor cells: 27 nCPM
- rod photoreceptor cells: 23 nCPM
Immune cell
- neutrophil: 1.4 nTPM
- eosinophil: 1 nTPM
- basophil: 0.7 nTPM
- NK-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
Brain region
- cerebellum: 16 nTPM
- white matter: 14 nTPM
- midbrain: 14 nTPM
- thalamus: 13 nTPM
- basal ganglia: 13 nTPM
- medulla oblongata: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.81
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of cytokine production
- regulation of immune system process
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZBTB34 as an antibody target. Whether an autoantibody or antibody against ZBTB34 could matter depends on whether native ZBTB34 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZBTB34 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZBTB34 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...